Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07466758) titled 'Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Biruni University
Condition:
Myosteatosis
Sarcopenia
Intervention:
Drug: Pharmaconutrition
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 16, 2024
Target Sample Size: 40
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/N...